Ohcanbohtosat - Yoshiro Saito

Characterization of serotonin as a candidate biomarker of severity and prognosis of COVID-19 using LC/MS analysis Dahkki Kosuke Saito, Rika Ishikawa, Isao Kitamura, Kumiko Ogawa, Noriaki Arakawa, Yuchen Sun, Kazuo Imai, Takuya Maeda, Yoshiro Saito, Chihiro Hasegawa

Connect to this object online.

Serum stratifin and presepsin as candidate biomarkers for early detection of COVID-19 disease progression Dahkki Noriaki Arakawa, Shinichiro Matsuyama, Masaru Matsuoka, Isao Kitamura, Keiko Miyashita, Yutaro Kitagawa, Kazuo Imai, Kumiko Ogawa, Takuya Maeda, Yoshiro Saito, Chihiro Hasegawa

Connect to this object online.

Differentiated HASTR/ci35 cells: A promising in vitro human astrocyte model for facilitating CNS drug development studies Dahkki Keita Kitamura, Ryo Ito, Kenta Umehara, Hanae Morio, Kosuke Saito, Shota Suzuki, Mari Hashimoto, Yoshiro Saito, Naohiko Anzai, Hidetaka Akita, Kan Chiba, Tomomi Furihata

Connect to this object online.

Real‐world evidence of population differences in allopurinol‐related severe cutaneous adverse reactions in East Asians: A population‐based cohort study Dahkki Tsugumichi Sato, Ching‐Lan Cheng, Heung‐Woo Park, Yea‐Huei Kao Yang, Min‐Suk Yang, Mizuki Fujita, Yuji Kumagai, Masahiro Tohkin, Yoshiro Saito, Kimie Sai

Connect to this object online.